🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 2 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/03/2025 10,12 10,49 9,96 10,32 +1,47% 5,19% 6.487.000
03/03/2025 10,74 10,83 10,15 10,17 -5,31% 6,33% 6.303.300
28/02/2025 10,33 10,76 10,33 10,74 +3,47% 4,16% 5.955.100
27/02/2025 10,61 10,72 10,37 10,38 -2,08% 3,25% 4.396.700
26/02/2025 10,56 10,79 10,48 10,60 +1,05% 2,98% 5.084.500
25/02/2025 10,53 10,62 10,35 10,49 -0,29% 2,56% 4.909.700
24/02/2025 10,66 10,72 10,49 10,52 -1,50% 2,16% 3.640.900
21/02/2025 10,72 10,86 10,67 10,68 -0,37% 1,73% 4.177.400
20/02/2025 10,66 10,79 10,62 10,72 +0,47% 1,55% 3.936.500
19/02/2025 10,62 10,86 10,60 10,67 -0,09% 2,45% 2.744.200
18/02/2025 10,56 10,82 10,55 10,68 +1,14% 2,51% 3.873.100
14/02/2025 10,48 10,62 10,42 10,56 +1,05% 1,91% 3.218.000
13/02/2025 10,39 10,51 10,33 10,45 +0,10% 1,78% 4.834.600
12/02/2025 10,35 10,67 10,33 10,44 -0,48% 3,29% 4.024.900
11/02/2025 10,76 10,77 10,49 10,49 -2,78% 2,60% 5.785.800
10/02/2025 11,41 11,51 10,76 10,79 -0,92% 6,57% 5.420.500
07/02/2025 10,83 11,09 10,82 10,89 +0,18% 2,45% 5.644.300
06/02/2025 11,01 11,03 10,84 10,87 -0,91% 1,77% 4.926.300
05/02/2025 10,92 11,06 10,87 10,97 +1,20% 1,79% 3.031.700
04/02/2025 10,77 10,85 10,66 10,84 +1,31% 1,81% 4.351.700
03/02/2025 10,93 10,98 10,70 10,70 -3,86% 2,61% 4.321.300
31/01/2025 11,41 11,48 11,12 11,13 -2,11% 3,16% 3.631.400
30/01/2025 11,18 11,42 11,18 11,37 +2,16% 2,15% 2.460.600
29/01/2025 11,10 11,25 11,05 11,13 -0,18% 1,82% 2.297.900
28/01/2025 11,19 11,22 11,01 11,15 +0,09% 1,92% 2.294.300
27/01/2025 11,09 11,42 11,00 11,14 -0,27% 3,79% 3.536.500
24/01/2025 11,16 11,30 11,09 11,17 -0,36% 1,88% 4.845.100
23/01/2025 11,09 11,24 11,00 11,21 +0,45% 2,16% 2.964.300
22/01/2025 11,30 11,37 11,08 11,16 -0,98% 2,57% 3.451.500
21/01/2025 11,22 11,38 11,13 11,27 +1,08% 2,27% 4.372.000